Comments

A novel tripartite STAT5B::RARA::RP11-750B16.1 fusion in variant acute promyelocytic leukemia. Comment on: "Novel ligand-binding domain truncated CPSF7::RARA::CPSF7 tripartite fusion confers primary ATRA resistance in atypical acute promyelocytic leukemia"

Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao 266000
Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao 266000
Haematologica Early view May 7, 2026 https://doi.org/10.3324/haematol.2026.301049